A Case of Nivolumab-Induced Myositis

Nivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. A case is presented of nivolumab-induced myositis, an unlisted side effect.

Detalles Bibliográficos
Autores principales: Fox, Eric, Dabrow, Michael, Ochsner, Greg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153342/
https://www.ncbi.nlm.nih.gov/pubmed/27864576
http://dx.doi.org/10.1634/theoncologist.2016-0170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153342/
https://www.ncbi.nlm.nih.gov/pubmed/27864576
http://dx.doi.org/10.1634/theoncologist.2016-0170

Ejemplares similares